HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Presence of anticardiolipin antibodies discriminates between Wegener's granulomatosis and microscopic polyarteritis.

Abstract
ANCA-tests are not always useful in evaluation of disease activity of patients with Wegener's granulomatosis (WG) and microscopic polyarteritis(MP). If ANCA-tests are failing in patients with Wegener's granulomatosis or microscopic polyarteritis, markers of activated coagulation are helpful in evaluation of disease activity. The measurement of anticardiolipin antibodies(ACA) may allow to discriminate between MP and WG, since ACA are only significantly elevated in patients with MP. Anticardiolipin antibodies (ACA) are acquired autoantibodies that are found in patients with a wide spectrum of clinical conditions, mainly systemic lupus erythematosus and related disorders. They are associated with increased thrombotic tendency. We investigated in patients with ANCA-positive vasculitis whether membrane phospholipids exposed in injured endothelial cells might stimulate the formation of ACA, thus contributing to the vascular thrombotic occlusion besides the activation of coagulation.
AuthorsO Hergesell, R Egbring, K Andrassy
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 336 Pg. 393-6 ( 1993) ISSN: 0065-2598 [Print] United States
PMID8296643 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Anticardiolipin
  • Antibodies, Antineutrophil Cytoplasmic
  • Autoantibodies
  • Immunoglobulin G
Topics
  • Adult
  • Aged
  • Antibodies, Anticardiolipin (blood)
  • Antibodies, Antineutrophil Cytoplasmic
  • Arteritis (diagnosis, immunology)
  • Autoantibodies (blood)
  • Diagnosis, Differential
  • Female
  • Granulomatosis with Polyangiitis (diagnosis, immunology)
  • Humans
  • Immunoglobulin G (blood)
  • Male
  • Middle Aged
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: